At Skyepharma, transparency is at the core of our Corporate Social Responsibility (CSR) commitment. As a leading CDMO (Contract Development and Manufacturing Organization), we continuously measure our ESG (Environmental, Social, and Governance) performance against the highest international standards.
In our latest EcoVadis assessment, Skyepharma achieved an overall score of 68/100. While this score reflects solid performance across all audited pillars, it earned us an EcoVadis Bronze Medal.
Here is an honest look into how the EcoVadis methodology works, a breakdown of our performance, and our action plan to push our sustainability standards even higher.
EcoVadis is the world’s most trusted provider of business sustainability ratings, assessing over 130,000 companies across global supply chains. Built on international Corporate Social Responsibility (CSR) standards, such as the United Nations Global Compact, the Global Reporting Initiative (GRI), and ISO 26000, EcoVadis evaluates performance across four main themes: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. For pharmaceutical companies and CDMOs like Skyepharma, an EcoVadis assessment provides an independent, rigorous, and globally recognized benchmark of ESG performance and supply chain transparency.
Since 2024, EcoVadis medals are no longer awarded based on absolute point thresholds. Instead, they are determined by a company’s percentile rank compared to all evaluated companies worldwide over the previous 12 months:
🥇 Platinum: Top 1% (99th+ percentile)
🥇 Gold: Top 5% (95th+ percentile)
🥈 Silver: Top 15% (85th+ percentile)
🥉 Bronze: Top 35% (65th+ percentile)
With a score of 68/100, Skyepharma sits at the 73rd percentile. This places us within the Top 27% of all assessed companies globally.
While being in the Top 27% easily qualifies us for the Bronze medal (which covers the top 35%), reaching the Silver medal required entering the Top 15%.
This distinction highlights an important reality: the global CSR benchmark is tightening every year. Companies worldwide are making significant progress, raising the standards for everyone. Our performance is strong and improving, but the bar to reach Silver and Gold continues to move higher, a challenge we welcome as a responsible CDMO.
EcoVadis evaluates companies across four key pillars. Here is a detailed look at Skyepharma’s scores, current achievements, and future targets for each domain.
Responsible supply chain management is critical in pharma manufacturing. This is currently our strongest performance area.
Operating with integrity, data security, and strict regulatory compliance is essential to maintaining trust with our pharmaceutical partners.
As a CDMO, minimizing our ecological footprint and mitigating climate risks are essential components of our operational roadmap.
Our people drive our success. We are building a fair, inclusive, and forward-thinking workplace culture.
Receiving an EcoVadis Bronze medal placing us in the Top 27% globally validates the robust groundwork Skyepharma has established over recent years. However, our vision does not stop here.
By addressing our target areas, expanding sustainable procurement coverage, deepening our climate adaptation strategy, and boosting representation in top pay scales, we are actively building the foundation required to reach Silver status and beyond in upcoming evaluations.
We remain committed to delivering safe, high-quality pharmaceutical products while driving positive environmental and social impact for our clients, employees, and communities.